메뉴 건너뛰기




Volumn 36, Issue 3, 2013, Pages 159-170

HLA-DPB1*05: 01-restricted WT1332-specific tcr-transduced CD4+ T lymphocytes display a helper activity for WT1-specific ctl induction and a cytotoxicity against leukemia cells

Author keywords

CD4+ helper T cell; helper peptide; HLA class II; TCR gene therapy; WT1

Indexed keywords

EPITOPE; GRANZYME B; HLA A ANTIGEN; HLA DPB1 ANTIGEN; LENTIVIRUS VECTOR; PERFORIN; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; WT1 PROTEIN; HLA A*24:02 ANTIGEN; HLA A24 ANTIGEN; HLA DP ANTIGEN; HLA DPB1*05:01 ANTIGEN; HLA-A*24:02 ANTIGEN; HLA-DPB1*05:01 ANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

EID: 84875357220     PISSN: 15249557     EISSN: 15374513     Source Type: Journal    
DOI: 10.1097/CJI.0b013e3182873581     Document Type: Article
Times cited : (18)

References (48)
  • 1
    • 33749031535 scopus 로고    scopus 로고
    • The many facets of the Wilms' tumour gene, WT1
    • Hohenstein P, Hastie ND. The many facets of the Wilms' tumour gene, WT1. Hum Mol Genet. 2006;15:R196-R201.
    • (2006) Hum Mol Genet. , vol.15
    • Hohenstein, P.1    Hastie, N.D.2
  • 2
    • 9244237089 scopus 로고    scopus 로고
    • Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: Implications for the involvement of WT1 in leukemogenesis
    • Yamagami T, Sugiyama H, Inoue K, et al. Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis. Blood. 1996;87:2878-2884.
    • (1996) Blood. , vol.87 , pp. 2878-2884
    • Yamagami, T.1    Sugiyama, H.2    Inoue, K.3
  • 3
    • 0032522925 scopus 로고    scopus 로고
    • Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells
    • Inoue K, Tamaki H, Ogawa H, et al. Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells. Blood. 1998;91:2969-2976.
    • (1998) Blood. , vol.91 , pp. 2969-2976
    • Inoue, K.1    Tamaki, H.2    Ogawa, H.3
  • 4
    • 0032944068 scopus 로고    scopus 로고
    • Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF)
    • Tsuboi A, Oka Y, Ogawa H, et al. Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF). Leuk Res. 1999;23:499-505.
    • (1999) Leuk Res. , vol.23 , pp. 499-505
    • Tsuboi, A.1    Oka, Y.2    Ogawa, H.3
  • 5
    • 0025099787 scopus 로고
    • Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus
    • Call KM, Glaser T, Ito CY, et al. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell. 1990;60:509-520.
    • (1990) Cell. , vol.60 , pp. 509-520
    • Call, K.M.1    Glaser, T.2    Ito, C.Y.3
  • 6
    • 0025098654 scopus 로고
    • Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping
    • Gessler M, Poustka A, Cavenee W, et al. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature. 1990;343:774-778.
    • (1990) Nature. , vol.343 , pp. 774-778
    • Gessler, M.1    Poustka, A.2    Cavenee, W.3
  • 7
    • 77952566271 scopus 로고    scopus 로고
    • WT1 (Wilms' tumor gene 1): Biology and cancer immunotherapy
    • Sugiyama H. WT1 (Wilms' tumor gene 1): biology and cancer immunotherapy. Jpn J Clin Oncol. 2010;40:377-387.
    • (2010) Jpn J Clin Oncol. , vol.40 , pp. 377-387
    • Sugiyama, H.1
  • 8
    • 0034112824 scopus 로고    scopus 로고
    • Human cytotoxic Tlymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1) product
    • Oka Y, Elisseeva OA, Tsuboi A, et al. Human cytotoxic Tlymphocyte responses specific for peptides of the wild-type Wilms' tumor gene (WT1) product. Immunogenetics. 2000;51: 99-107.
    • (2000) Immunogenetics. , vol.51 , pp. 99-107
    • Oka, Y.1    Elisseeva, O.A.2    Tsuboi, A.3
  • 9
    • 0033966369 scopus 로고    scopus 로고
    • HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide
    • Ohminami H, Yasukawa M, Fujita S. HLA class I-restricted lysis of leukemia cells by a CD8(+) cytotoxic T-lymphocyte clone specific for WT1 peptide. Blood. 2000;95:286-293.
    • (2000) Blood. , vol.95 , pp. 286-293
    • Ohminami, H.1    Yasukawa, M.2    Fujita, S.3
  • 10
    • 4644289323 scopus 로고    scopus 로고
    • Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression
    • Oka Y, Tsuboi A, Taguchi T, et al. Induction of WT1 (Wilms' tumor gene)-specific cytotoxic T lymphocytes by WT1 peptide vaccine and the resultant cancer regression. Proc Natl Acad Sci USA. 2004;101:13885-13890.
    • (2004) Proc Natl Acad Sci USA. , vol.101 , pp. 13885-13890
    • Oka, Y.1    Tsuboi, A.2    Taguchi, T.3
  • 11
    • 84861999235 scopus 로고    scopus 로고
    • Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease
    • Tsuboi A, Oka Y, Kyo T, et al. Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease. Leukemia. 2011;26:1410-1413.
    • (2011) Leukemia. , vol.26 , pp. 1410-1413
    • Tsuboi, A.1    Oka, Y.2    Kyo, T.3
  • 12
    • 33745686444 scopus 로고    scopus 로고
    • A phase I/II trial of a WT1 (Wilms' tumor gene) peptide vaccine in patients with solid malignancy: Safety assessment based on the phase i data
    • Morita S, Oka Y, Tsuboi A, et al. A phase I/II trial of a WT1 (Wilms' tumor gene) peptide vaccine in patients with solid malignancy: safety assessment based on the phase I data. Jpn J Clin Oncol. 2006;36:231-236.
    • (2006) Jpn J Clin Oncol. , vol.36 , pp. 231-236
    • Morita, S.1    Oka, Y.2    Tsuboi, A.3
  • 13
    • 69049089548 scopus 로고    scopus 로고
    • The prioritization of cancer antigens: A national cancer institute pilot project for the acceleration of translational research
    • Cheever MA, Allison JP, Ferris AS, et al. The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clin Cancer Res. 2009;15:5323-5337.
    • (2009) Clin Cancer Res. , vol.15 , pp. 5323-5337
    • Cheever, M.A.1    Allison, J.P.2    Ferris, A.S.3
  • 14
    • 80051611504 scopus 로고    scopus 로고
    • Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety
    • Ochi T, Fujiwara H, Okamoto S, et al. Novel adoptive T-cell immunotherapy using a WT1-specific TCR vector encoding silencers for endogenous TCRs shows marked antileukemia reactivity and safety. Blood. 2011;118:1495-1503.
    • (2011) Blood. , vol.118 , pp. 1495-1503
    • Ochi, T.1    Fujiwara, H.2    Okamoto, S.3
  • 15
    • 27644566777 scopus 로고    scopus 로고
    • Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells
    • Xue SA, Gao L, Hart D, et al. Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells. Blood. 2005;106:3062-3067.
    • (2005) Blood. , vol.106 , pp. 3062-3067
    • Xue, S.A.1    Gao, L.2    Hart, D.3
  • 16
    • 79952187823 scopus 로고    scopus 로고
    • T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis
    • Parkhurst MR, Yang JC, Langan RC, et al. T cells targeting carcinoembryonic antigen can mediate regression of metastatic colorectal cancer but induce severe transient colitis. Mol Ther. 2011;19:620-626.
    • (2011) Mol Ther. , vol.19 , pp. 620-626
    • Parkhurst, M.R.1    Yang, J.C.2    Langan, R.C.3
  • 17
    • 78650410673 scopus 로고    scopus 로고
    • Development of human anti-murine T-cell receptor antibodies in both responding and nonresponding patients enrolled in TCR gene therapy trials
    • Davis JL, Theoret MR, Zheng Z, et al. Development of human anti-murine T-cell receptor antibodies in both responding and nonresponding patients enrolled in TCR gene therapy trials. Clin Cancer Res. 2010;16:5852-5861.
    • (2010) Clin Cancer Res. , vol.16 , pp. 5852-5861
    • Davis, J.L.1    Theoret, M.R.2    Zheng, Z.3
  • 18
    • 84855533370 scopus 로고    scopus 로고
    • Cytotoxic CD4 T cells in antiviral immunity
    • Marshall NB, Swain SL. Cytotoxic CD4 T cells in antiviral immunity. J Biomed Biotechnol. 2011;2011:954602.
    • (2011) J Biomed Biotechnol. , vol.2011 , pp. 954602
    • Marshall, N.B.1    Swain, S.L.2
  • 19
    • 0037456367 scopus 로고    scopus 로고
    • CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
    • Janssen EM, Lemmens EE, Wolfe T, et al. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature. 2003;421:852-856.
    • (2003) Nature. , vol.421 , pp. 852-856
    • Janssen, E.M.1    Lemmens, E.E.2    Wolfe, T.3
  • 20
    • 45549099784 scopus 로고    scopus 로고
    • Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1
    • Hunder NN, Wallen H, Cao J, et al. Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1. N Engl J Med. 2008;358:2698-2703.
    • (2008) N Engl J Med. , vol.358 , pp. 2698-2703
    • Hunder, N.N.1    Wallen, H.2    Cao, J.3
  • 21
    • 77949522803 scopus 로고    scopus 로고
    • Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
    • Quezada SA, Simpson TR, Peggs KS, et al. Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts. J Exp Med. 2010;207:637-650.
    • (2010) J Exp Med. , vol.207 , pp. 637-650
    • Quezada, S.A.1    Simpson, T.R.2    Peggs, K.S.3
  • 22
    • 34247174293 scopus 로고    scopus 로고
    • Identification and characterization of a WT1 (Wilms Tumor Gene) protein-derived HLA-DRB1*0405-restricted 16-mer helper peptide that promotes the induction and activation of WT1-specific cytotoxic T lymphocytes
    • Fujiki F, Oka Y, Tsuboi A, et al. Identification and characterization of a WT1 (Wilms Tumor Gene) protein-derived HLA-DRB1*0405-restricted 16-mer helper peptide that promotes the induction and activation of WT1-specific cytotoxic T lymphocytes. J Immunother. 2007;30:282-293.
    • (2007) J Immunother. , vol.30 , pp. 282-293
    • Fujiki, F.1    Oka, Y.2    Tsuboi, A.3
  • 23
    • 59449087616 scopus 로고    scopus 로고
    • A WT1 protein-derived, naturally processed 16-mer peptide, WT1(332), is a promiscuous helper peptide for induction of WT1-specific Th1-type CD4(+) T cells
    • Fujiki F, Oka Y, Kawakatsu M, et al. A WT1 protein-derived, naturally processed 16-mer peptide, WT1(332), is a promiscuous helper peptide for induction of WT1-specific Th1-type CD4(+) T cells. Microbiol Immunol. 2008;52:591-600.
    • (2008) Microbiol Immunol. , vol.52 , pp. 591-600
    • Fujiki, F.1    Oka, Y.2    Kawakatsu, M.3
  • 24
    • 23744460167 scopus 로고    scopus 로고
    • Direct recognition and lysis of leukemia cells by WT1-specific CD4+ T lymphocytes in an HLA class II-restricted manner
    • Guo Y, Niiya H, Azuma T, et al. Direct recognition and lysis of leukemia cells by WT1-specific CD4+ T lymphocytes in an HLA class II-restricted manner. Blood. 2005;106:1415-1418.
    • (2005) Blood. , vol.106 , pp. 1415-1418
    • Guo, Y.1    Niiya, H.2    Azuma, T.3
  • 25
    • 77955064368 scopus 로고    scopus 로고
    • A clear correlation between WT1-specific Th response and clinical response in WT1 CTL epitope vaccination
    • Fujiki F, Oka Y, Kawakatsu M, et al. A clear correlation between WT1-specific Th response and clinical response in WT1 CTL epitope vaccination. Anticancer Res. 2010;30:2247-2254.
    • (2010) Anticancer Res. , vol.30 , pp. 2247-2254
    • Fujiki, F.1    Oka, Y.2    Kawakatsu, M.3
  • 26
    • 0026513471 scopus 로고
    • Co-expression of human T cell receptor chains with mouse CD3 on the cell surface of a mouse T cell hybridoma
    • ZumLa A, Marguerie C, So A, et al. Co-expression of human T cell receptor chains with mouse CD3 on the cell surface of a mouse T cell hybridoma. J Immunol Methods. 1992;149:69-76.
    • (1992) J Immunol Methods. , vol.149 , pp. 69-76
    • Zumla, A.1    Marguerie, C.2    So, A.3
  • 27
    • 0028006324 scopus 로고
    • Establishment of a new cell line with the characteristics of a multipotential progenitor from a patient with chronic myelogenous leukemia in early erythroblastic crisis
    • Furukawa T, Koike T, Ying W, et al. Establishment of a new cell line with the characteristics of a multipotential progenitor from a patient with chronic myelogenous leukemia in early erythroblastic crisis. Leukemia. 1994;8:171-180.
    • (1994) Leukemia. , vol.8 , pp. 171-180
    • Furukawa, T.1    Koike, T.2    Ying, W.3
  • 28
    • 0036566202 scopus 로고    scopus 로고
    • Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies
    • Elisseeva OA, Oka Y, Tsuboi A, et al. Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies. Blood. 2002;99:3272-3279.
    • (2002) Blood. , vol.99 , pp. 3272-3279
    • Elisseeva, O.A.1    Oka, Y.2    Tsuboi, A.3
  • 29
    • 67449088945 scopus 로고    scopus 로고
    • WT1 IgG antibody for early detection of nonsmall cell lung cancer and as its prognostic factor
    • Oji Y, Kitamura Y, Kamino E, et al. WT1 IgG antibody for early detection of nonsmall cell lung cancer and as its prognostic factor. Int J Cancer. 2009;125:381-387.
    • (2009) Int J Cancer. , vol.125 , pp. 381-387
    • Oji, Y.1    Kitamura, Y.2    Kamino, E.3
  • 30
    • 0033743984 scopus 로고    scopus 로고
    • Cell death induction by CTL: Perforin/granzyme B system dominantly acts for cell death induction in human hepatocellular carcinoma cells
    • Hayashida M, Kawano H, Nakano T, et al. Cell death induction by CTL: perforin/granzyme B system dominantly acts for cell death induction in human hepatocellular carcinoma cells. Proc Soc Exp Biol Med. 2000;225:143-150.
    • (2000) Proc Soc Exp Biol Med. , vol.225 , pp. 143-150
    • Hayashida, M.1    Kawano, H.2    Nakano, T.3
  • 31
    • 27144557584 scopus 로고    scopus 로고
    • A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles
    • Chattopadhyay PK, Yu J, Roederer M. A live-cell assay to detect antigen-specific CD4+ T cells with diverse cytokine profiles. Nat Med. 2005;11:1113-1117.
    • (2005) Nat Med. , vol.11 , pp. 1113-1117
    • Chattopadhyay, P.K.1    Yu, J.2    Roederer, M.3
  • 32
    • 77953457564 scopus 로고    scopus 로고
    • Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinase
    • Frankel TL, Burns WR, Peng PD, et al. Both CD4 and CD8 T cells mediate equally effective in vivo tumor treatment when engineered with a highly avid TCR targeting tyrosinase. J Immunol. 2010;184:5988-5998.
    • (2010) J Immunol. , vol.184 , pp. 5988-5998
    • Frankel, T.L.1    Burns, W.R.2    Peng, P.D.3
  • 33
    • 22144447521 scopus 로고    scopus 로고
    • Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes
    • Tsuji T, Yasukawa M, Matsuzaki J, et al. Generation of tumor-specific, HLA class I-restricted human Th1 and Tc1 cells by cell engineering with tumor peptide-specific T-cell receptor genes. Blood. 2005;106:470-476.
    • (2005) Blood. , vol.106 , pp. 470-476
    • Tsuji, T.1    Yasukawa, M.2    Matsuzaki, J.3
  • 34
    • 77955270629 scopus 로고    scopus 로고
    • MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro
    • Ray S, Chhabra A, Chakraborty NG, et al. MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitro. Clin Immunol. 2010;136:338-347.
    • (2010) Clin Immunol. , vol.136 , pp. 338-347
    • Ray, S.1    Chhabra, A.2    Chakraborty, N.G.3
  • 35
    • 78649878384 scopus 로고    scopus 로고
    • Transplantation of mouse HSCs genetically modified to express a CD4-restricted TCR results in long-term immunity that destroys tumors and initiates spontaneous autoimmunity
    • Ha SP, Klemen ND, Kinnebrew GH, et al. Transplantation of mouse HSCs genetically modified to express a CD4-restricted TCR results in long-term immunity that destroys tumors and initiates spontaneous autoimmunity. J Clin Invest. 2010;120: 4273-4288.
    • (2010) J Clin Invest. , vol.120 , pp. 4273-4288
    • Ha, S.P.1    Klemen, N.D.2    Kinnebrew, G.H.3
  • 36
    • 33747872062 scopus 로고    scopus 로고
    • Transduction of an HLADP4- restricted NY-ESO-1-specific TCR into primary human CD4+ lymphocytes
    • Zhao Y, Zheng Z, Khong HT, et al. Transduction of an HLADP4- restricted NY-ESO-1-specific TCR into primary human CD4+ lymphocytes. J Immunother. 2006;29:398-406.
    • (2006) J Immunother. , vol.29 , pp. 398-406
    • Zhao, Y.1    Zheng, Z.2    Khong, H.T.3
  • 37
    • 80052342180 scopus 로고    scopus 로고
    • Generating HPV specific T helper cells for the treatment of HPV induced malignancies using TCR gene transfer
    • Scholten KB, Turksma AW, Ruizendaal JJ, et al. Generating HPV specific T helper cells for the treatment of HPV induced malignancies using TCR gene transfer. J Transl Med. 2011;9:147.
    • (2011) J Transl Med. , vol.9 , pp. 147
    • Scholten, K.B.1    Turksma, A.W.2    Ruizendaal, J.J.3
  • 38
    • 0032473562 scopus 로고    scopus 로고
    • Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors
    • Ossendorp F, Mengedé E, Camps M, et al. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors. J Exp Med. 1998;187:693-702.
    • (1998) J Exp Med. , vol.187 , pp. 693-702
    • Ossendorp, F.1    Mengedé, E.2    Camps, M.3
  • 39
    • 84862776631 scopus 로고    scopus 로고
    • Preexisting influenzaspecific CD4+ T cells correlate with disease protection against influenza challenge in humans
    • Wilkinson TM, Li CK, Chui CS, et al. Preexisting influenzaspecific CD4+ T cells correlate with disease protection against influenza challenge in humans. Nat Med. 2012;18: 274-280.
    • (2012) Nat Med. , vol.18 , pp. 274-280
    • Wilkinson, T.M.1    Li, C.K.2    Chui, C.S.3
  • 40
    • 39649115582 scopus 로고    scopus 로고
    • The transcriptome of human cytotoxic T cells: Similarities and disparities among allostimulated CD4(+) CTL, CD8(+) CTL and NK cells
    • Hidalgo LG, Einecke G, Allanach K, et al. The transcriptome of human cytotoxic T cells: similarities and disparities among allostimulated CD4(+) CTL, CD8(+) CTL and NK cells. Am J Transplant. 2008;8:627-636.
    • (2008) Am J Transplant. , vol.8 , pp. 627-636
    • Hidalgo, L.G.1    Einecke, G.2    Allanach, K.3
  • 41
    • 77950858633 scopus 로고    scopus 로고
    • Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy
    • Brown DM. Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy. Cell Immunol. 2010;262: 89-95.
    • (2010) Cell Immunol. , vol.262 , pp. 89-95
    • Brown, D.M.1
  • 42
    • 0344406265 scopus 로고    scopus 로고
    • Association of ovarian tumor epithelium coexpressing HLA-DR and CA-125 antigens with tumor infiltrating cytotoxic T lymphocytes
    • Matsushita N, Ghazizadeh M, Konishi H, et al. Association of ovarian tumor epithelium coexpressing HLA-DR and CA-125 antigens with tumor infiltrating cytotoxic T lymphocytes. J Nihon Med Sch. 2003;70:40-44.
    • (2003) J Nihon Med Sch. , vol.70 , pp. 40-44
    • Matsushita, N.1    Ghazizadeh, M.2    Konishi, H.3
  • 43
    • 0242624621 scopus 로고    scopus 로고
    • Targeted therapy of solid malignancies via HLA class II antigens: A new biotherapeutic approach
    • Altomonte M, Fonsatti E, Visintin A, et al. Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach? Oncogene. 2003;22:6564-6569.
    • (2003) Oncogene , vol.22 , pp. 6564-6569
    • Altomonte, M.1    Fonsatti, E.2    Visintin, A.3
  • 44
    • 2542429298 scopus 로고    scopus 로고
    • Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: A follow-up study from the Leukemia and LymphomaMolecular Profiling Project
    • Rimsza LM, Roberts RA, Miller TP, et al. Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and LymphomaMolecular Profiling Project. Blood. 2004;103:4251-4258.
    • (2004) Blood. , vol.103 , pp. 4251-4258
    • Rimsza, L.M.1    Roberts, R.A.2    Miller, T.P.3
  • 45
    • 84860417122 scopus 로고    scopus 로고
    • Human alloreactive CD4+ T cells as strong mediators of anti-tumor immunity in NOD/scid mice engrafted with human acute lymphoblastic leukemia
    • Stevanović S, Griffioen M, Nijmeijer BA, et al. Human alloreactive CD4+ T cells as strong mediators of anti-tumor immunity in NOD/scid mice engrafted with human acute lymphoblastic leukemia. Leukemia. 2012;26:312-322.
    • (2012) Leukemia. , vol.26 , pp. 312-322
    • Stevanović, S.1    Griffioen, M.2    Nijmeijer, B.A.3
  • 46
    • 0242708508 scopus 로고    scopus 로고
    • Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis
    • Loøvig T, Andersen SN, Thorstensen L, et al. Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis. Br J Cancer. 2002; 87:756-762.
    • (2002) Br J Cancer. , vol.87 , pp. 756-762
    • Loøvig, T.1    Andersen, S.N.2    Thorstensen, L.3
  • 47
    • 0037428757 scopus 로고    scopus 로고
    • On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases
    • Bernsen MR, Hakansson L, Gustafsson B, et al. On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases. Br J Cancer. 2003;88: 424-431.
    • (2003) Br J Cancer. , vol.88 , pp. 424-431
    • Bernsen, M.R.1    Hakansson, L.2    Gustafsson, B.3
  • 48
    • 84861231609 scopus 로고    scopus 로고
    • Tumor-specific CD4+ melanoma tumor-infiltrating lymphocytes
    • Friedman KM, Prieto PA, Devillier LE, et al. Tumor-specific CD4+ melanoma tumor-infiltrating lymphocytes. J Immunother. 2012;35:400-408.
    • (2012) J Immunother. , vol.35 , pp. 400-408
    • Friedman, K.M.1    Prieto, P.A.2    Devillier, L.E.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.